[NBIX] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
05-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 958.52%
YoY- 556.31%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 296,000 258,500 222,094 151,757 60,774 0 0 -
PBT 30,500 -57,100 58,407 50,764 -11,125 -36,887 -34,435 -
Tax 8,000 500 4,618 7,672 7,337 -1,549 -1,409 -
NP 22,500 -57,600 53,789 50,764 -11,125 -36,887 -34,435 -
Tax Rate -26.23% - -7.91% -15.11% - - - -
Total Cost 273,500 316,100 168,305 100,993 71,899 36,887 34,435 41.20%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 7.60 -22.28 24.22 33.45 -18.31 0.00 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS 0.24 -0.62 0.59 0.56 -0.13 -0.43 -0.40 -
EPS Diluted 0.23 -0.62 0.56 0.52 -0.13 -0.43 -0.40 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.